首页> 外国专利> Amino substituted piperidine Derivatives, Pharmaceutical compositions and the use of these derivatives for the preparation of drugs as inhibitors of gamma secretase, and for the treatment of Alzheimer's disease

Amino substituted piperidine Derivatives, Pharmaceutical compositions and the use of these derivatives for the preparation of drugs as inhibitors of gamma secretase, and for the treatment of Alzheimer's disease

机译:氨基取代的哌啶衍生物,药物组合物以及这些衍生物在制备药物中作为γ分泌酶抑制剂的用途以及在治疗阿尔茨海默氏病中的用途

摘要

Amino substituted piperidine Derivatives, comprising a compound of the formula (1) or pharmaceutically acceptable salts or solvates thereof, wherein: aR1 and ar2 are independently selected from aryl and heteroaryl; and it's a Link.Or represents a Group (- C (R3) 1 - 3 - 2); each R1 is independently selected from alkyl (C1: 6); aryl; aryl substituted with one or more substituents CF3, independently selected from Halogen, alkyl, alkoxy (C1 - 6) (C1 - 6), ocf3, NH2 or heteroaryl heteroaryl substituted; NC; One or more substituents independently selected from Halogen, alkyl (C1 - CF3, 6),Alkoxy (C1 - 6), ocf3, NH2 or CN; Halogen; - Cf3; - ocf3; CN; NO2 -; - NH2, - C (o) nhalquilo (C1 - 6) - C (o) n (alkyl (C1 - 6) 2, where the alkyl group (C1 - 6) is equal to or different from the other, - C (o) n (alkyl (C1 - 6) 2Where the alkyl group (C1 - 6) is equal to or different from the others and the alkyl groups (C1 - 6) taken together with nitrogen which are United to form a Ring; - NHC (or alkyl (C1) - 6 - (NHC), or oalquilo (C1) - 6) - NHC (O) nhalquilo (C1 - 6)- nhso2alquilo (C1 - 6); Oh; OC (or alkyl (C1) - 6 - (C1); oalquilo - 6); oarilo; or - oaralquilo (C1 - 6); each R2 is independently selected from alkyl (C1: 6); Halogen; - Cf3 - ocf3;; CN; No2 -; - NH2, - C (o) oalquilo (C1 - 6 - C (o); (6) nhalquilo C1 - (alkyl) - N (C1 - 2 - 6) where each Substituent alkyd ILO (C1 - 6) is equal to or different from the other; n - (alkyl (C1 - 6) 2Where each Substituent alkyl (C1 - 6) is equal to or different from the other and alkyl substituents (C1 - 6)Along with the nitrogen Atom to which they are United to form a Ring; - NHC (or alkyl (C1) - 6 - (NHC); or oalquilo (C1) - 6 - (NHC); or nhalquilo (C1) - 6 - (C1); nhso2alquilo - 6); - OC (- Oh; or alkyl (C1) - 6 - (C1); oalquilo - 6); oarilo OAR; alkyl; aryl (C1 - 6); aryl substituted with one or more substituents inde Among them: CF3, halogen, alkyl, alkoxy (C1 - 6) (C1 - 6), ocf3,NH2 or heteroaryl heteroaryl substituted; CN; with one or more substituents CF3, independently selected from Halogen, alkyl, alkoxy (C1 - 6) (C1 - 6) ocf3, NH2 or CN, - C (o) n (alkyl (C1 - 6) 2 where each alkyl group is independently selected; C (o) n (alkyl (C1 2 - 6) where each group) PO is independently selected where the alkyl and alkyl groups,Taken together with the nitrogen Atom.Form a ring heterocicloalquilo; or a selected Group among the remains of formulas (2) to (6); each R3 is independently selected from H and alkyl (c1-3); each is independently selected from alkyl R4: (c1-3); Oh; or - oalquilo (c1-3); R5 is selected among Hydrogen; Alkyl (C1 - 6); aryl heteroaryl; rent; - (c1-3) - oalquilo (c1-3); - Rent (C1 - (6) - s or - C1 2alquilo (0)3); - Rent (C1 - 8) - S (o) 0 - 2nhalquilo (c1-3); (o) - C (C1 - 6 alkyl (or aryl); (c) - C (o) aralquilo (c1-3) - C (o) - heteroaryl; C (o) heteroaralquilo (c1-3) - C (o) oalquilo (C1 - 6) - C (o) nhalquilo (C1 - 6) - C (o) n (alkyl (C1 - 6) 2, where each alkyl group C1 - 6 is equal or different from others; - C (o) n (alkyl ( C1 - 6) 2Where the alkyl group C1 - 6 is equal or different from the others and where the alkyl groups C1 - 6, taken together with the nitrogen which are United,Form a ring heterocicloalquilo; - C (o) Rent (c1-3) - nhalquilo (c1-3) - C (o) Rent (c1-3) n - (alkyl (c1-3); 2 where each alkyl group is selected independently; - so2alquilo (C1 - 6); - so2nhalquilo (C1 - 6); so2n (alkyl (C1 - 6); 2 where each alkyl group C1 - 6 is the same or different L Other so2n; - (alkyl (C1 - 6) 2Where the alkyl group C1 - 6 is equal or different from the others and where the alkyl groups C1 - 6, taken together with the nitrogen which are United to form a ring heterocicloalquilo or a group of the formula (7), (8), (9) or (10); R6 - H (C1 - 6) or alkyl; X is selected between CH2, or, S, so, SO2 or N - R7; R7 is selected from alkyl, cycloalkyl (C1 - 6) (C3 - 6)Rent (c1-3) - cycloalkyl (C3 - 6); aralquilo aryl, heteroaryl (c1-3), heteroaralquilo (c1-3) alkyl, - C (o) (C1 - 6), C (aryl) -, - C (o) aralquilo (c1-3), - C (or C - (heteroaryl); or (3) heteroaralquilo C1 -, - C (o) oalquilo (C1 -, - C (6) or (6) nhalquilo C1 -, - C (o) n (alkyl (C1 - 6) 2, where each group C1 - 6 is the same L or different to others; - C (o) n (alkyl (C1 - 6) 2Where the alkyl group C1 - 6 is equal or different from the others and where the alkyl groups C1 - 6, taken together with the nitrogen which are United to form a ring heterocicloalquilo; - C (o) Rent (c1-3) - nhalquilo (c1-3), rent (- C (o) C1 - (alkyl) - n 3 (c1-3)) 2Where the c1-3 alkyl groups are equal or different; or - Rent (c1-3) - o-alkyl (c1-3); n and P are independently selected from 0 to 3 to form a Ring of 4 to 7 members; R is 0 to 3; Q represents 0 to 3 and t is 0 to 3.It also describes Pharmaceutical compositions and the use of such compounds for preparing Medicines for inhibiting the gamma secretase and for the treatment of Alzheimer's disease.
机译:包含式(1)化合物或其药学上可接受的盐或溶剂化物的氨基取代的哌啶衍生物,其中:aR1和ar2独立地选自芳基和杂芳基;或代表一个群组(-C(R3)1-3-2);每个R 1独立地选自烷基(C 1:6);芳基被一个或多个取代基CF 3取代的芳基,其独立地选自卤素,烷基,烷氧基(C 1-6)(C 1-6),ocf 3,NH 2或被杂芳基取代的杂芳基; NC;一个或多个独立地选自卤素,烷基(C 1 -CF 3,6),烷氧基(C 1-6),ocf 3,NH 2或CN的取代基;卤素; -Cf3; -ocf3; CN; NO2-; -NH 2--C(o)nhalquilo(C1-6)-C(o)n(烷基(C1-6)2,其中烷基(C1-6)彼此相同或不同,-C( o)n(烷基(C1-6)2),其中烷基(C1-6)彼此相同或不同,烷基(C1-6)与氮合在一起形成环;-NHC (或烷基(C1)-6-(NHC)或oalquilo(C1)-6)-NHC(O)nhalquilo(C1-6)-nhso2 alquilo(C1-6);哦; OC(或烷基(C1)- 6-(C1); oalquilo-6); oarilo;或-oaralquilo(C1-6);每个R2独立选自烷基(C1:6);卤素;-Cf3-ocf3 ;; CN; No2--;-NH2 ,-C(o)alquilo(C1-6-C(o);(6)nhalquilo C1-(烷基)-N(C1-6-6)其中每个取代醇酸ILO(C1-6)相同或不同n-(烷基(C1-6)2)其中每个取代基烷基(C1-6)彼此相同或不同,且烷基取代基(C1-6)连同它们共同形成的氮原子一个环;-NHC(或烷基(C1)-6 -(NHC);或oalquilo(C1)-6-(NHC);或nhalquilo(C1)-6-(C1); nhso2alquilo-6); -OC(-哦;或烷基(C1)-6-(C1); oalquilo-6); oarilo OAR;烷基;芳基(C1-6);被一个或多个取代基取代的芳基;其中CF3,卤素,烷基,烷氧基(C1-6)(C1-6),ocf3,NH2或杂芳基取代。 CN;具有一个或多个独立地选自卤素,烷基,烷氧基(C1-6)(C1-6)ocf3,NH2或CN的取代基CF3--C(o)n(烷基(C1-6)2独立选择; C(o)n(烷基(C1 2-6),其中每个基团)PO独立地选自烷基和烷基,与氮原子一起形成环杂环喹啉;或选自其余的基团式(2)至(6)的化合物;每个R 3独立地选自H和烷基(c 1-3);每个独立地选自烷基R 4:(c1-3); Oh;或-oalquilo(c1-3); R5选自氢;烷基(C1-6);芳基杂芳基;地租;-(c1-3)-oalquilo(c1-3);-地租(C1-(6)-s或-C1 2alquilo(0)3 );-租金(C1-8)-S(o)0-2 nhalquilo(c1-3);(o)-C(C1-6烷基(或芳基);(c)-C(o)芳基(c1- 3)-C(o)-杂芳基; C(o)杂芳基(c1-3)-C(o)芳基(C1-6)-C(o)萘基(C1-6)-C(o)n(烷基(C1-6)2,其中每个烷基C1-6相等或与他人不同; -C(o)n(烷基(C1-6)2,其中烷基C1-6彼此相同或不同,并且烷基C1-6与氮一起被结合在一起,形成环杂环烷基; -C(o)租(c1-3)-nhalquilo(c1-3)-C(o)租(c1-3)n-(烷基(c1-3); 2其中每个烷基均独立选择;-so2alquilo (C1-6); -so2nhalquilo(C1-6); so2n(烷基(C1-6); 2其中每个烷基C1-6相同或不同L其他so2n;-(烷基(C1-6)2)其中烷基C1-6彼此相同或不同,并且烷基C1-6与氮一起被结合形成环杂环烷基或式(7),(8),(9)的基团)或(10); R6-H(C1-6)或烷基; X选自CH2或S,因此,SO2或N-R7; R7选自烷基,环烷基(C1-6)(C3- 6)租(c1-3)-环烷基(C3-6);芳基芳基,杂芳基(c1-3),杂芳基(c1-3)烷基,-C(o)(C1-6),C(芳基)- , -C(o)aralquilo(c1-3),-C(或C-(杂芳基);或(3)杂芳基C1-,-C(o)oalquilo(C1-,-C(6)或(6)nhalquilo C1-,-C(o)n(烷基(C1-6))2,其中每个基团C1 -6是相同的L或彼此不同;-C(o)n(烷基(C1-6)2)其中烷基C1-6是彼此相同或不同,并且烷基C1-6是与联合形成环杂环氯基的氮;-C(o)租(c1-3)-nhalquilo(c1-3),租(-C(o)C1-(烷基)-n 3(c1-3) )2其中c1-3烷基相同或不同;或-Rent(c1-3)-o-烷基(c1-3); n和P独立选自0至3以形成4至7个成员的环; R为0至3; Q为0至3且t为0至3。它还描述了药物组合物以及此类化​​合物在制备用于抑制γ分泌酶的药物和用于治疗阿尔茨海默氏病中的用途。

著录项

  • 公开/公告号AR035260A1

    专利类型

  • 公开/公告日2004-05-05

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号AR2002P102925

  • 发明设计人

    申请日2002-08-01

  • 分类号C07D211/56;C07D221/58;C07D211/62;C07D211/96;C07D207/14;C07D401/12;C07D405/12;C07D401/06;C07D409/06;C07D405/06;C07D403/06;A61K31/4468;A61K31/4462;A61K31/40;A61P25/28;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号